USE OF CAPTOPRIL AS A CARDIOPROTECTOR AND ANTI-INFLAMMATORY FOR HEART TROUBLE ASSOCIATED WITH ARTERIAL HYPERTENSION

The invention relates to the use of an angiotensin-converting enzyme inhibitor (ACE inhibitor), captopril, for controlling the cardiac inflammatory process that accompanies arterial hypertension based on the reduction of pro-inflammatory cytokine levels. The invention also relates to pharmaceutical...

Full description

Saved in:
Bibliographic Details
Main Authors VAZQUEZ CUETO, CARMEN MA, MATE BARRERO, ALFONSO, MIGUEL CARRASCO, JOSE LUIS, MONSERRAT GARCIA, MARIA TERESA
Format Patent
LanguageEnglish
French
Spanish
Published 14.07.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to the use of an angiotensin-converting enzyme inhibitor (ACE inhibitor), captopril, for controlling the cardiac inflammatory process that accompanies arterial hypertension based on the reduction of pro-inflammatory cytokine levels. The invention also relates to pharmaceutical compositions for treating said alteration, comprising a therapeutically effective quantity of captopril. La presente invención se refiere al uso de un inhibidor de la enzima convertidora de la angiotensina I (IECA), el captopril, para combatir el proceso inflamatorio cardiaco que acompaña a la hipertensión arterial basado en la disminución de los niveles de citoquinas proinflamatorias. Del mismo modo, esta invención también está referida a composiciones farmaceúticas para el tratamiento de la citada alteración, que comprendan una cantidad terapeúticamente efectiva de captopril. La présente invention concerne l'utilisation d'un inhibiteur de l'enzyme de conversion de l'angiotensine (IECA), le captopril, pour lutter contre le processus inflammatoire cardiaque accompagnant l'hypertension artérielle fondé sur la réduction des niveaux de cytokines pro-inflammatoires. Cette invention concerne également des compositions pharmaceutiques destinées au traitement de l'altération susmentionnée, lesquelles comprennent une quantité thérapeutiquement efficace de captopril.
Bibliography:Application Number: WO2010ES00294